DCVC Bio L.P. 13D and 13G filings for AbCellera Biologics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:24 pm Sale |
2021-12-31 | 13G | AbCellera Biologics Inc. ABCL |
DCVC Bio L.P. | 7,305,761 2.600% |
-21,800,000 (-74.90%) |
Filing |
| 2021-02-09 06:24 am Purchase |
2020-12-31 | 13G | AbCellera Biologics Inc. ABCL |
DCVC Bio L.P. | 29,105,761 10.800% |
29,105,761 (New Position) |
Filing |